Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by jdstoxon Dec 05, 2017 10:40am
169 Views
Post# 27092878

RE:RE:RE:RE:RE:RE:RE:today's news

RE:RE:RE:RE:RE:RE:RE:today's news"Could" could mean anything, couldn't "could," beenthere?

I'd like to know the supporting information that could lead anybody to speculate that this could take another 6 years to produce any SP-driving news.

We had a PR yesterday that expressed very clearly the expeditious manner in which this is being moved forward. (Clear the decks. We're going into battle!)

Nancy Stagliano has had three big wins in her career so far, two of them taking place, START TO FINISH, in the last six years, the same length of time in which some of you speculate that nothing may happen at Bioasis. That speculation is unsupportable and is nothing more than anonymous attention-seeking blather.

On her LinkedIn page Nancy Stagliano describes herself as a "Serial Biotech Entrepreneur." Entrepreneur, everybody, entrepreneur!! That's her own assessment and description of herself. This is not a lab worker in a shark's suit! This is a shark in a lab coat! This is a you-skin-this-one,-pilgrim,-I'm-going-for-another-one type of character. (Will Geer quote from "Jeremiah Johnson.")

About the whole gang, Day, Stagliano, Rathjen, Radhakrishnan, Lowe, Tian, London and the rest, these are not people who sit around and yap about how long things might take. These people do things. Collectively they have maybe 100 to 150 years of post-graduate and corporate accomplishment at the very highest levels of performance. Not a pretender in the lot!

And I don't see anybody on here really even trying to figure out what it means to a company when a bunch of wild-eyed git 'er done kind of hard-asses, like we've got, come on board and push the "Go" button.

It's time for some of you to start figuring out what these things might mean.

jdstox

Bullboard Posts